Emmaus Life Sciences Files 2024 10-K
Ticker: EMMA · Form: 10-K · Filed: Apr 14, 2025 · CIK: 822370
| Field | Detail |
|---|---|
| Company | Emmaus Life Sciences, INC. (EMMA) |
| Form Type | 10-K |
| Filed Date | Apr 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Emmaus Life Sciences filed its 2024 10-K, detailing financials and operations.
AI Summary
Emmaus Life Sciences, Inc. filed its 2024 10-K on April 14, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as MYnd Analytics, Inc., is involved in the pharmaceutical preparations industry. The filing details its business operations, financial performance, and risk factors.
Why It Matters
This filing provides investors and the public with a comprehensive overview of Emmaus Life Sciences' financial health and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Emmaus Life Sciences faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 1231 — Fiscal Year End (Indicates the end of the reporting period)
- 001-35527 — SEC File Number (Identifier for the company's SEC filings)
Key Players & Entities
- Emmaus Life Sciences, Inc. (company) — Filer
- MYnd Analytics, Inc. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 2025-04-14 (date) — Filing date
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of Emmaus Life Sciences, Inc.?
Emmaus Life Sciences, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code 2834.
When was the 10-K filing for the fiscal year 2024 submitted?
The 10-K filing for the fiscal year 2024 was submitted on April 14, 2025.
What were Emmaus Life Sciences' former company names?
Emmaus Life Sciences, Inc. was formerly known as MYnd Analytics, Inc., CNS RESPONSE, INC., and STRATIVATION, INC.
What is the company's business address?
The company's business address is 21250 Hawthorne Boulevard, Suite 800, Torrance, CA 90503.
What is the SEC file number for Emmaus Life Sciences?
The SEC file number for Emmaus Life Sciences is 001-35527.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 14, 2025 regarding Emmaus Life Sciences, Inc. (EMMA).